Evaluation of the Safety and Efficacy of VIGADEXA Ophthalmic Gel Compared to VIGADEXA Ophthalmic Solution in Preventing Inflammation and Infection Following Cataract Surgery

Trial Profile

Evaluation of the Safety and Efficacy of VIGADEXA Ophthalmic Gel Compared to VIGADEXA Ophthalmic Solution in Preventing Inflammation and Infection Following Cataract Surgery

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 16 May 2014

At a glance

  • Drugs Moxifloxacin/dexamethasone (Primary)
  • Indications Bacterial infections; Inflammation
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 25 Mar 2014 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
    • 28 Jun 2013 Planned End Date changed from 1 Jul 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 15 Nov 2012 Planned end date changed from 1 Oct 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top